• Profile
Close

New application of dydrogesterone as a part of a progestin-primed ovarian stimulation protocol for IVF: A randomized controlled trial including 516 first IVF/ICSI cycles

Human Reproduction Jan 10, 2018

Yu S, et al. - A randomized controlled trial, including 516 first IVF/ICSI cycles, was performed to assess the utility of dydrogesterone (DYG) as an alternative progestin in a progesterone primed ovarian stimulation (PPOS) protocol. DYG exhibited no or only weak inhibition of ovulation in normal dosage and could serve as an hMG adjuvant during ovarian stimulation. Finding thus suggested a new possible utility of DYG: as an appropriate alternative progestin for a PPOS protocol in IVF.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay